BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sato-Espinoza K, Chotiprasidhi P, Liza E, Placido-Damian Z, Diaz-Ferrer J. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World J Transplant 2024; 14(4): 98718 [PMID: 39697455 DOI: 10.5500/wjt.v14.i4.98718]
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/98718.htm
Number Citing Articles
1
Farinaz Ghodrati, Ashley B Zhang, Nadim Mahmud. MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyondGastroenterology Report 2026; 14 doi: 10.1093/gastro/goag006
2
B. Sakhova, A. Oshibayeva, N. Nuskabayeva, E. Iskandirova, Zh. Rsalieva, N. Karabayev, L. Karimova, L. Ozbakyr. PREVALENCE OF VARIOUS ETIOPATHOGENIC VARIANTS OF CHRONIC DIFFUSE LIVER DISEASESMedicine and ecology 2025; (3): 35 doi: 10.59598/ME-2305-6053-2025-116-3-35-47
3
Arijeet K. Gattu, Lindsay T. Fourman. Metabolic dysfunction-associated steatotic liver disease in people with HIVCurrent Opinion in HIV and AIDS 2025; 20(4): 350 doi: 10.1097/COH.0000000000000952
4
Javier Diaz-Ferrer, Perapa Chotiprasidhi, Mayra Valdivia-Herrera, Karina Sato-Espinoza. Hepatocellular carcinoma in patients without cirrhosisWorld Journal of Gastroenterology 2025; 31(23): 107100 doi: 10.3748/wjg.v31.i23.107100
5
Paulina Carpinteyro-Espin, María Isabel Astudillo-Delgado, Graciela Elia Castro-Narro, Aline Huerta-Álvarez, Juanita Pérez-Escobar. Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor poolWorld Journal of Gastroenterology 2025; 31(37): 110164 doi: 10.3748/wjg.v31.i37.110164